购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • AChR
    (2)
  • Cholinesterase (ChE)
    (2)
  • Others
    (7)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 35日内发货
    (2)
  • 6-8周
    (4)
  • 10-14周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "physostigmine"的结果
筛选
搜索结果
TargetMol产品目录中 "

physostigmine

"的结果
  • 抑制剂&激动剂
    11
    TargetMol | Inhibitors_Agonists
  • 天然产物
    2
    TargetMol | Natural_Products
  • Physostigmine
    毒扁豆碱, Physostol, Ezerin, Esromiotin, Eserine, Antilirium
    T2143857-47-6
    Physostigmine is a potent and reversible inhibitor of cholinesterase. It is also reported to form a slowly degrading carbamylated enzyme complex with acetylcholinesterase (AChE).
    5日内发货
    询价
  • Physostigmine Salicylate
    水杨酸依色林, 水杨酸毒扁豆碱
    T013057-64-7
    Physostigmine salicylate 是一种可逆的乙酰胆碱酯酶抑制剂,也一种是抗胆碱能中毒的解毒剂。它可透过血脑屏障并刺激中枢胆碱能神经传递。它能逆转阿尔茨海默病转基因小鼠的记忆缺陷。
    • ¥ 397
    In stock
    规格
    数量
  • Physostigmine hemisulfate
    毒扁豆碱半硫酸盐
    T2315364-47-1
    cholinesterase inhibitor
    • 待估
    35日内发货
    规格
    数量
  • Neostigmine bromide
    溴化新斯的明, Neoserine bromide, Eustigmin bromide
    T1624114-80-7
    Neostigmine Bromide 是一种胆碱酯酶抑制剂,不会穿过血脑屏障,可作用于重症肌无力。
    • ¥ 220
    In stock
    规格
    数量
  • Neostigmine
    T6902959-99-4
    Neostigmine is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
    • 待询
    6-8周
    规格
    数量
  • Phenserine
    (-)-Eseroline phenylcarbamate, (-)-Phenserine
    T12446101246-66-6
    Phenserine is a derivative of Physostigmine and is annoncompetitive, long-acting and selective inhibitor of AChE.
    • ¥ 5960
    6-8周
    规格
    数量
  • Biperiden Hydrochloride
    KL 373 (Hydrochloride),盐酸比哌立登
    T146141235-82-1
    Biperiden Hydrochloride (KL 373 Hydrochloride) is an antiparkinsonian agent, which is the selective central M1 cholinoreceptors blocker and it is used for the adjunctive treatment of all forms of Parkinson's disease (postencephalitic, idiopathic, and arte
    • 待估
    35日内发货
    规格
    数量
  • Neostigmine hydroxide
    T69050588-17-0
    Neostigmine hydroxide is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier.
    • ¥ 10600
    6-8周
    规格
    数量
  • Cymserine
    T70607145209-39-8
    Cymserine is a drug related to physostigmine, which acts as a reversible cholinesterase inhibitor, with moderate selectivity for the plasma cholinesterase enzyme butyrylcholinesterase, and relatively weaker inhibition of the better-known acetylcholinesterase enzyme.
    • ¥ 10600
    6-8周
    规格
    数量
  • (-)-Eseroline fumarate
    T7393070310-73-5
    (-)-Eseroline fumarate 是一种 AChE 抑制剂 Physostigmine 的代谢产物。(-)-Eseroline fumarate 引起癌细胞的乳酸脱氢酶 (LDH) 泄漏。(-)-Eseroline fumarate 还诱导神经元细胞释放腺嘌呤核苷酸和5-羟色胺 (5-HT),从而诱导细胞死亡。(-)-Eseroline fumarate 抑制小鼠输精管和豚鼠回肠的电诱发抽搐。
    • 待询
    规格
    数量
  • Phenserine tartrate
    (-)-Phenserine (+)-tartrate,(-)-Eseroline phenylcarbamate tartrate
    T89337156910-61-1
    Phenserine tartrate ((-)-Eseroline phenylcarbamate) 作为Physostigmine的衍生物,此化合物是一种高效、非竞争性、长效及选择性的AChE抑制剂.它能显著减少β-淀粉样蛋白前体蛋白(APP)与β-淀粉样肽(Aβ)的生成,从而改善认知功能并减缓阿尔茨海默氏病的发展速度.
    • 待询
    10-14周
    规格
    数量
没有更多数据了